-
1
-
-
35348936097
-
Highlights of the third international workshop on HIV and hepatitis coinfection
-
Vogel M, Rockstroh J. Highlights of the third international workshop on HIV and hepatitis coinfection. Expert Rev. Anti Infect. Ther. 5(5), 769-771 (2007).
-
(2007)
Expert Rev. Anti Infect. Ther
, vol.5
, Issue.5
, pp. 769-771
-
-
Vogel, M.1
Rockstroh, J.2
-
2
-
-
16844377066
-
Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison]
-
Saiz de la Hoya P, Bedia M, Murcia J, Cebria J, Sanchez-Paya J, Portilla J. [Predictive markers of HIV and HCV infection and co-infection among inmates in a Spanish prison]. Enferm. Infecc. Microbiol. Clin. 23(2), 53-57 (2005).
-
(2005)
Enferm. Infecc. Microbiol. Clin
, vol.23
, Issue.2
, pp. 53-57
-
-
Saiz de la Hoya, P.1
Bedia, M.2
Murcia, J.3
Cebria, J.4
Sanchez-Paya, J.5
Portilla, J.6
-
3
-
-
30144437514
-
Epidemiology of viral hepatitis and HIV co-infection
-
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol. 44(1 Suppl.), S6-S9 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Alter, M.J.1
-
4
-
-
20044369545
-
Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]
-
Laguno M, Sanchez-Tapias JM, Murillas J et al. [Advances in the diagnosis and treatment of hepatitis C virus infection in patients with and without HIV infection]. Enferm. Infecc. Microbiol. Clin. 23(1), 32-40 (2005).
-
(2005)
Enferm. Infecc. Microbiol. Clin
, vol.23
, Issue.1
, pp. 32-40
-
-
Laguno, M.1
Sanchez-Tapias, J.M.2
Murillas, J.3
-
5
-
-
30144436182
-
Influence of HIV co-infection on hepatitis C immunopathogenesis
-
Koziel MJ. Influence of HIV co-infection on hepatitis C immunopathogenesis. J. Hepatol. 44(1 Suppl.), S14-S18 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Koziel, M.J.1
-
6
-
-
20144389653
-
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients
-
Alberti A, Clumeck N, Collins S et al. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J. Hepatol. 42(5), 615-624 (2005).
-
(2005)
J. Hepatol
, vol.42
, Issue.5
, pp. 615-624
-
-
Alberti, A.1
Clumeck, N.2
Collins, S.3
-
7
-
-
30144439971
-
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection
-
Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J. Hepatol. 44(1 Suppl.), S28-34 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Vallet-Pichard, A.1
Pol, S.2
-
8
-
-
0035200295
-
Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients
-
Martin-Carbonero L, Soriano V, Valencia E, Garcia-Samaniego J, Lopez M, Gonzalez-Lahoz J. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res. Hum. Retroviruses 17(16), 1467-1471 (2001).
-
(2001)
AIDS Res. Hum. Retroviruses
, vol.17
, Issue.16
, pp. 1467-1471
-
-
Martin-Carbonero, L.1
Soriano, V.2
Valencia, E.3
Garcia-Samaniego, J.4
Lopez, M.5
Gonzalez-Lahoz, J.6
-
9
-
-
33745217423
-
2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus
-
2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus. J. Viral Hepat. 13(7), 466-473 (2006).
-
(2006)
J. Viral Hepat
, vol.13
, Issue.7
, pp. 466-473
-
-
Moreno, A.1
Barcena, R.2
Garcia-Garzon, S.3
-
12
-
-
33947366502
-
2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
-
2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. J. Viral Hepat. 14(4), 228-238 (2006).
-
(2006)
J. Viral Hepat
, vol.14
, Issue.4
, pp. 228-238
-
-
Crespo, M.1
Sauleda, S.2
Esteban, J.I.3
-
13
-
-
0033054813
-
-
EASL international consensus conference on hepatitis C. Paris, 26-28, February 1999, consensus statement. European Association for the Study of the Liver. J. Hepatol. 30(5), 956-961 (1999).
-
EASL international consensus conference on hepatitis C. Paris, 26-28, February 1999, consensus statement. European Association for the Study of the Liver. J. Hepatol. 30(5), 956-961 (1999).
-
-
-
-
14
-
-
2442683905
-
2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3
-
2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3. J. Hepatol. 40(6), 993-999 (2004).
-
(2004)
J. Hepatol
, vol.40
, Issue.6
, pp. 993-999
-
-
Zeuzem, S.1
Hultcrantz, R.2
Bourliere, M.3
-
15
-
-
4444270265
-
2b plus ribavirin for treatment of HIV/HCV co-infected patients
-
2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 18(13), F27-F36 (2004).
-
(2004)
AIDS
, vol.18
, Issue.13
-
-
Laguno, M.1
Murillas, J.2
Blanco, J.L.3
-
16
-
-
0035934568
-
2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358(9286), 958-965 (2001).
-
(2001)
Lancet
, vol.358
, Issue.9286
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
-
17
-
-
30144444473
-
Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management
-
Mauss S. Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. J. Hepatol. 44(1 Suppl.), S114-S118 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Mauss, S.1
-
18
-
-
30144444611
-
Options for treatment of hepatitis C in HIV-infected persons
-
Thomas DL. Options for treatment of hepatitis C in HIV-infected persons. J. Hepatol. 44(1 Suppl.), S40-S43 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Thomas, D.L.1
-
19
-
-
55249123297
-
-
PegIntron®, package insert. Schering-Plough Corporation. NJ, USA, June 2007
-
PegIntron®, package insert. Schering-Plough Corporation. NJ, USA, June (2007).
-
-
-
-
20
-
-
55249111456
-
-
Rebetol®, package insert. Schering-Plough Corporation. NJ, USA, July 2007
-
Rebetol®, package insert. Schering-Plough Corporation. NJ, USA, July (2007).
-
-
-
-
21
-
-
23644443360
-
-
Grace MJ, Cutler DL, Bordens RW. Pegylated IFNs for chronic hepatitis C: an update. Expert Opin. Drug Deliv. 2(2), 219-226 (2005).
-
Grace MJ, Cutler DL, Bordens RW. Pegylated IFNs for chronic hepatitis C: an update. Expert Opin. Drug Deliv. 2(2), 219-226 (2005).
-
-
-
-
22
-
-
10644244360
-
Pegylating IFNs at His-34 improves the in vitro antiviral activity through the JAK/STAT pathway
-
Grace MJ, Cutler D. Pegylating IFNs at His-34 improves the in vitro antiviral activity through the JAK/STAT pathway. Antivir. Chem. Chemother. 15(6), 287-297 (2004).
-
(2004)
Antivir. Chem. Chemother
, vol.15
, Issue.6
, pp. 287-297
-
-
Grace, M.J.1
Cutler, D.2
-
23
-
-
0033429408
-
Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C
-
Thomas HC, Torok ME, Forton DM, Taylor-Robinson SD. Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C. J. Hepatol. 31(Suppl. 1), 152-159 (1999).
-
(1999)
J. Hepatol
, vol.31
, Issue.SUPPL. 1
, pp. 152-159
-
-
Thomas, H.C.1
Torok, M.E.2
Forton, D.M.3
Taylor-Robinson, S.D.4
-
24
-
-
20044385757
-
Site of pegylation and polyethylene glycol molecule size attenuate interferon-α antiviral and antiproliferative activities through the JAK/STAT signaling pathway
-
Grace MJ, Lee S, Bradshaw S et al. Site of pegylation and polyethylene glycol molecule size attenuate interferon-α antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J. Biol. Chem. 280(8), 6327-6336 (2005).
-
(2005)
J. Biol. Chem
, vol.280
, Issue.8
, pp. 6327-6336
-
-
Grace, M.J.1
Lee, S.2
Bradshaw, S.3
-
25
-
-
18444405565
-
Pharmacokinetics of pegylated interferons: What is misleading?
-
Caliceti P. Pharmacokinetics of pegylated interferons: what is misleading? Dig. Liver Dis. 36(Suppl. 3), S334-S339 (2004).
-
(2004)
Dig. Liver Dis
, vol.36
, Issue.SUPPL. 3
-
-
Caliceti, P.1
-
26
-
-
0034324083
-
-
2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group
-
2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin. Pharmacol. Ther. 68(5), 556-567 (2000).
-
(2000)
Clin. Pharmacol. Ther
, vol.68
, Issue.5
, pp. 556-567
-
-
Glue, P.1
Fang, J.W.2
Rouzier-Panis, R.3
-
27
-
-
48349109857
-
Peginterferons for the treatment of chronic hepatitis C
-
Grace MJ, Bordens RW, Cutler DL. Peginterferons for the treatment of chronic hepatitis C. Hepatology Rev. 2, 3-9 (2005).
-
(2005)
Hepatology Rev
, vol.2
, pp. 3-9
-
-
Grace, M.J.1
Bordens, R.W.2
Cutler, D.L.3
-
30
-
-
0032949443
-
The clinical pharmacology of ribavirin
-
Glue P. The clinical pharmacology of ribavirin. Semin. Liver Dis. 19 (Suppl, 1), 17-24 (1999).
-
(1999)
Semin. Liver Dis
, vol.19
, Issue.SUPPL.and 1
, pp. 17-24
-
-
Glue, P.1
-
31
-
-
0346098340
-
Ribavirin pharmacokinetics in renal and liver transplant patients: Evidence that it depends on renal function
-
Kamar N, Chatelut E, Manolis E, Lafont T, Izopet J, Rostaing L. Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. Am. J. Kidney Dis. 43(1), 140-146 (2004).
-
(2004)
Am. J. Kidney Dis
, vol.43
, Issue.1
, pp. 140-146
-
-
Kamar, N.1
Chatelut, E.2
Manolis, E.3
Lafont, T.4
Izopet, J.5
Rostaing, L.6
-
32
-
-
0033844251
-
2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group
-
2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. Hepatology 32(3), 647-653 (2000).
-
(2000)
Hepatology
, vol.32
, Issue.3
, pp. 647-653
-
-
Glue, P.1
Rouzier-Panis, R.2
Raffanel, C.3
-
33
-
-
10344230440
-
2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
-
2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292(23), 2839-2848(2004).
-
(2004)
JAMA
, vol.292
, Issue.23
, pp. 2839-2848
-
-
Carrat, F.1
Bani-Sadr, F.2
Pol, S.3
-
34
-
-
2942696419
-
Viral factors affecting the outcome of therapy for chronic hepatitis C
-
Fried MW. Viral factors affecting the outcome of therapy for chronic hepatitis C. Rev. Gastroenterol. Disord. 4(Suppl. 1), S8-S13 (2004).
-
(2004)
Rev. Gastroenterol. Disord
, vol.4
, Issue.SUPPL. 1
-
-
Fried, M.W.1
-
35
-
-
30144435322
-
Treatment of chronic hepatitis C in HIV-positive individuals: Selection of candidates
-
Soriano V. Treatment of chronic hepatitis C in HIV-positive individuals: selection of candidates. J. Hepatol. 44(1 Suppl.), S44-S48 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Soriano, V.1
-
36
-
-
33845430865
-
Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: Interferon induces HR independent of sustained virologic response (SVR)
-
Wu L, Kottilil S, Lempicki R et al. Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: interferon induces HR independent of sustained virologic response (SVR). AIDS Res. Hum. Retroviruses 22(11), 1091-1098 (2006).
-
(2006)
AIDS Res. Hum. Retroviruses
, vol.22
, Issue.11
, pp. 1091-1098
-
-
Wu, L.1
Kottilil, S.2
Lempicki, R.3
-
37
-
-
15744381704
-
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
-
Romero-Gomez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128(3), 636-641 (2005).
-
(2005)
Gastroenterology
, vol.128
, Issue.3
, pp. 636-641
-
-
Romero-Gomez, M.1
Del Mar Viloria, M.2
Andrade, R.J.3
-
38
-
-
0035393683
-
Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy
-
Duong M, Petit JM, Piroth L et al. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 27(3), 245-250 (2001).
-
(2001)
J. Acquir. Immune Defic. Syndr
, vol.27
, Issue.3
, pp. 245-250
-
-
Duong, M.1
Petit, J.M.2
Piroth, L.3
-
39
-
-
36349022057
-
2b in African Americans with hepatitis C virus genotype 1
-
2b in African Americans with hepatitis C virus genotype 1. Hepatology 46(4), 982-990 (2007).
-
(2007)
Hepatology
, vol.46
, Issue.4
, pp. 982-990
-
-
Jacobson, I.M.1
Brown Jr, R.S.2
McCone, J.3
-
40
-
-
36348974683
-
True' weight-based dosing versus 'flat' dosing of ribavirin: Will the WIN-R please come forward?
-
Smith J, Han SH. 'True' weight-based dosing versus 'flat' dosing of ribavirin: will the WIN-R please come forward? Hepatology 46(4), 953-956 (2007).
-
(2007)
Hepatology
, vol.46
, Issue.4
, pp. 953-956
-
-
Smith, J.1
Han, S.H.2
-
41
-
-
11244327853
-
Management of hepatitis C
-
Teo M, Hayes P. Management of hepatitis C. Br. Med. Bull. 70, 51-69 (2004).
-
(2004)
Br. Med. Bull
, vol.70
, pp. 51-69
-
-
Teo, M.1
Hayes, P.2
-
42
-
-
0038555663
-
2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
-
2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17(7), 1023-1028 (2003).
-
(2003)
AIDS
, vol.17
, Issue.7
, pp. 1023-1028
-
-
Perez-Olmeda, M.1
Nunez, M.2
Romero, M.3
-
43
-
-
30144443736
-
Treatment algorithm for the management of hepatitis C in HIV-coinfected persons
-
Sulkowski MS. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons. J. Hepatol. 44(1 Suppl.), S49-S55 (2006).
-
(2006)
J. Hepatol
, vol.44
, Issue.1 SUPPL.
-
-
Sulkowski, M.S.1
-
44
-
-
34247624140
-
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: Does abacavir play a role?
-
Bani-Sadr F, Denoeud L, Morand P, et al. Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role? J. Acquir. Immune Defic. Syndr. 45, 123-125 (2007).
-
(2007)
J. Acquir. Immune Defic. Syndr
, vol.45
, pp. 123-125
-
-
Bani-Sadr, F.1
Denoeud, L.2
Morand, P.3
-
45
-
-
33745501500
-
2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
-
2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. J. Infict. 53(1), 36-42 (2006).
-
(2006)
J. Infict
, vol.53
, Issue.1
, pp. 36-42
-
-
Voigt, E.1
Schulz, C.2
Klausen, G.3
-
46
-
-
21844477798
-
Open, randomized, multicentre italian trial on PEG-IFN-plus ribavirin versus PEG-IFN-monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART
-
Cargnel A, Angeli E, Mainini A et al. Open, randomized, multicentre italian trial on PEG-IFN-plus ribavirin versus PEG-IFN-monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART. Antivir. Ther. 10(2), 309-317 (2005).
-
(2005)
Antivir. Ther
, vol.10
, Issue.2
, pp. 309-317
-
-
Cargnel, A.1
Angeli, E.2
Mainini, A.3
-
47
-
-
33646163653
-
2b Plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
-
2b Plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS Res. Hum. Retroviruses 22(4), 315-320 (2006).
-
(2006)
AIDS Res. Hum. Retroviruses
, vol.22
, Issue.4
, pp. 315-320
-
-
Santin, M.1
Shaw, E.2
Garcia, M.J.3
-
48
-
-
1642546905
-
2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
-
2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients. AIDS 18(1), 67-73 (2004).
-
(2004)
AIDS
, vol.18
, Issue.1
, pp. 67-73
-
-
Moreno, L.1
Quereda, C.2
Moreno, A.3
-
49
-
-
12144289459
-
Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: Indications for the investigation of new treatment approaches
-
Ballesteros AL, Franco S, Fuster D et al. Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection: indications for the investigation of new treatment approaches. AIDS 18(1), 59-66 (2004).
-
(2004)
AIDS
, vol.18
, Issue.1
, pp. 59-66
-
-
Ballesteros, A.L.1
Franco, S.2
Fuster, D.3
-
51
-
-
36949015153
-
Old and emerging therapies in chronic hepatitis C: An update
-
Deutsch M, Hadziyannis SJ. Old and emerging therapies in chronic hepatitis C: an update. J. Viral Hepat. 15(1), 2-11 (2008).
-
(2008)
J. Viral Hepat
, vol.15
, Issue.1
, pp. 2-11
-
-
Deutsch, M.1
Hadziyannis, S.J.2
|